Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    14736930 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed SORAVE - Sorafenib and Everolimus in Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific;   Non-Small Cell Lung Cancer
Intervention: Drug: Combination of sorafenib and everolimus
2 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Lungcancer
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
3 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET

Study has passed its completion date and status has not been verified in more than two years.